Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells

American Journal of Transplantation

Volumn 5, Issue 10, 2005, Pages 2378-2384

  Csencsits, Keri ^a   Wood, Sherri Chan ^a   Lu, Guanyi ^a   Bishop, D Keith ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Adenoviruses; Gene therapy; Graft acceptance; Heart; T cells; Transforming growth factor beta (TGF )

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GENE TRANSFER; GRAFT SURVIVAL; HEART TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T CELL DEPLETION; TRANSGENE; ADENOVIRUS; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL TRANSPLANTATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GRAFT REJECTION; HUMAN; METABOLISM; METHODOLOGY; REOPERATION; SPLEEN; TIME;

ADENOVIRIDAE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REOPERATION; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSGENES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644690906     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01042.x     Document Type: Article

References (43)

1. Chen D Sung R Bromberg JS. Gene therapy in transplantation. Transpl Immunol 2002 9 : 301 314.
2. Giannoukakis N Thomson A Robbins P. Gene therapy in transplantation. Gene Ther 1999 6 : 1499 1511.
3. Wilson JM. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996 334 : 1185 1187.
4. Kay MA Glorioso JC Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001 7 : 33 40.
5. Vilquin JT Guerette B Kinoshita I et al. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther 1995 6 : 1391 1401.
6. Yang Y Jooss KU Su Q Ertl HC Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996 3 : 137 144.
7. Yang Y Li Q Ertl HC Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995 69 : 2004 2015.
8. Chan SY Li K Piccotti JR et al. Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants. Nat Med 1999 5 : 1143 1149.
9. Letterio JJ Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998 16 : 137 161.
10. Schmitt E Hoehn P Huels C et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994 24 : 793 798.
11. Gamble JR Khew-Goodall Y Vadas MA. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J Immunol 1993 150 : 4494 4503.
12. Inge TH Hoover SK Susskind BM Barrett SK Bear HD. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor β1. Cancer Res 1992 52 : 1386 1392.
13. Holder MJ Knox K Gordon J. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-β, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis. Eur J Immunol 1992 22 : 2725 2728.
14. Lomo J Blomhoff HK Beiske K Stokke T Smeland EB. TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995 154 : 1634 1643.
15. Bogdan C Nathan C. Modulation of macrophage function by transforming growth factor β interleukin-4, and interleukin-10. Ann N Y Acad Sci 1993 685 : 713 739.
16. Qin L Chavin KD Ding Y et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation 1995 59 : 809 816.
17. Brauner R Nonoyama M Laks H et al. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. J Thorac Cardiovasc Surg 1997 114 : 923 933.
18. Chan SY Goodman RE Szmuszkovicz JR Roessler B Eichwald EJ Bishop DK. DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor β1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor β1. Transplantation 2000 70 : 1292 1301.
19. Csencsits KL Bishop DK. Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction. Am J Transplant 2003 3 : 107 115.
20. Wood KJ Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 : 199 210.
21. Brunner AM Marquardt H Malacko AR Lioubin MN Purchio AF. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J Biol Chem 1989 264 : 13660 13664.
22. Roessler BJ Hartman JW Vallance DK Latta JM Janich SL Davidson BL. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum Gene Ther 1995 6 : 307 316.
23. Danielpour D Dart LL Flanders KC Roberts AB Sporn MB. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol 1989 138 : 79 86.
24. Corry RJ Winn HJ Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
25. Lu G Bishop DK. Theoretical and technical considerations for gene transfer into vascularized cardiac transplants. In : Metzger JM, ed. Methods in molecular biology: cardiac cell and gene transfer: principals, protocols, and applications. Totowa, New Jersey : Humana Press Inc, 2003 : 135.
26. Nathan MJ Mold JE Wood SC et al. Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells. J Immunol 2004 172 : 6626 6633.
27. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004 172 : 6003 6010.
28. Hori S Nomura T Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 1061.
29. + regulatory T cells. Nat Immunol 2003 4 : 330 336.
30. Qin L Ding Y Pahud DR Chang E Imperiale MJ Bromberg JS. Promoter attenuation in gene therapy: interferon-γ and tumor necrosis factor-α inhibit transgene expression. Hum Gene Ther 1997 8 : 2019 2029.
31. Fu S Zhang N Yopp AC et al. TGF-β induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am J Transplant 2004 4 : 1614 1627.
32. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003 198 : 1875 1886.
33. + T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004 4 : 65 78.
34. + immunoregulatory cells. J Immunol 2001 167 : 1137 1140.
35. + T cell function but not expansion. Nat Immunol 2002 3 : 1208 1213.
36. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002 169 : 5401 5404.
37. Nathan MJ Yin D Eichwald EJ Bishop DK. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant 2002 2 : 323 332.
38. Yin D Dujovny N Ma L et al. IFN-γ production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol 2003 170 : 853 860.
39. Piccotti JR Li K Chan SY et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998 160 : 1132 1138.
40. + T cells. J Exp Med 1999 189 : 1355 1360.
41. Szabo SJ Sullivan BM Stemmann C Satoskar AR Sleckman BP Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 2002 295 : 338 342.
42. Gorelik L Constant S Flavell RA. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J Exp Med 2002 195 : 1499 1505.
43. + T cell function by the transcription factor Eomesodermin. Science 2003 302 : 1041 1043.